Effects of electroporation on anticancer activity of 5-FU and newly synthesized zinc(II) complex in chemotherapy-resistance human brain tumor cells

• Published in: Medical oncology (Northwood, London, England) London, England), 2021-11, Vol.38 (11), p.129-129, Article 129
• Main Authors: Alkış, Mehmet Eşref, Turan, Nevin, Alan, Yusuf, Irtegun Kandemir, Sevgi, Buldurun, Kenan
• Format: Article
• Language: English
• Subjects: Antineoplastic Agents - pharmacology; Brain cancer; Brain Neoplasms - drug therapy; Brain Neoplasms - pathology; Cell Line, Tumor; Chemotherapy; Cytotoxicity; Drug Resistance, Neoplasm; Electrochemotherapy; Electroporation; Fluorouracil - pharmacology; Hematology; Humans; Internal Medicine; Medicine; Medicine & Public Health; Oncology; Original Paper; Pathology; Zinc Compounds - chemistry; Zinc Compounds - pharmacology
• ISSN: 1357-0560; 1559-131X
• DOI: 10.1007/s12032-021-01579-7

Zn(II) complex of Schiff base derived from the condensation of 4-aminopyrimidine-2(1 H )-one with salicylaldehyde was prepared and characterized by various physico‐chemical and spectral methods for structure determination. The cytotoxic activity of the Zn(II) complex was investigated in comparison with 5-fluorouracil (5-FU) against two different human brain tumor cell lines (T98G and U118), while primer human dermal fibroblast cells (HDF) was used as control for biocompatibility. Then, the effectiveness of electroporation (EP) on cytotoxic activities of these compounds has been examined. The cytotoxicities of the 5-FU and new Zn(II) complex, alone or in combination with electroporation, were determined by MTT assay. The Zn(II) complex showed good cytotoxicity against T98G and U118 brain tumor cell lines with IC 50  = 282.47 and 297.91 μM respectively, while it was safe on HDF healthy cells with IC 50  = 826.72 μM. The 5-FU exhibited less cytotoxicity compared to the Zn(II) complex against T98G (IC 50  = 382.35 μM) and U118 (IC 50  = 396.56 μM) tumor cell lines. The combined application of Zn (II) + EP decreased the IC 50 value by 5.96-fold in T98G cells and 4.76-fold in U118 cells. EP showed a similar effect in its combined application with 5-FU, resulting in a decrease of the IC 50 value of 4.22-fold in the T98G cells and 3.84-fold in the U118 cells. In a conclusion, the Zn(II) complex exhibited an anticancer potential against both brain tumor cell lines (T98G and U118) and EP greatly increased the cytotoxicity of Zn(II) complex and 5-FU on these chemotherapy-resistant cells. Graphic Abstract